Cipla Share price Target 2025, 2026, 2027 to 2030

Do you want to know the Cipla share price target for the year 2025? Here, you will get a detailed analysis of the company’s financial performance, historical data, and price target for the year 2025, 2026, 2027, 2028, 2029, and 2030 provided by the market experts and analysts.

About Cipla Ltd

Cipla Limited is a company from India that makes and shares medicines to help people stay healthy. It began in 1935 in Mumbai. Cipla does not make finished pills only—it also creates the important parts inside medicines, which help treat illnesses like asthma, diabetes, infections, and heart problems. The company sends these medicines and ingredients to many countries around the world. Cipla’s work aims to make medicines that are safe, good-quality, and affordable for everyone.

Cipla Fundamentals

• Market Cap: ₹1,23,674.79Cr.
• P/E Ratio: 23.98
• Book Value: ₹396.75
• Dividend Yield: 1.05%
• ROE: 17.20 %
• ROCE: 21.59%
• 52-Week High: ₹1,702
• 52-Week Low: ₹1,310.05

Cipla Shareholding Pattern

• Promoter: 29.19%
• FII: 25.24%
• DII: 29.25%
• Public: 16.31%
• Others: 0%

Cipla Share Price Historical Data

Cipla Share Price Target 2025

In 2025, the minimum price of Cipla shares will be ₹1650. Over the year, it is expected to go up little by little and its maximum price could reach about ₹1900. So, the stock may trade between ₹1650 and ₹1900 during the year.

Cipla Share Price Target 2026

In 2026, the minimum price of Cipla shares will be ₹1950. Over the year, it is expected to go up little by little and its maximum price could reach about ₹2400. So, the stock may trade between ₹1950 and ₹2400 during the year.

Cipla Share Price Target 2027

In 2027, the minimum price of Cipla shares will be ₹2500. Over the year, it is expected to go up little by little and its maximum price could reach about ₹2900. So, the stock may trade between ₹2500 and ₹2900 during the year.

Cipla Share Price Target 2028

In 2028, the minimum price of Cipla shares will be ₹2950. Over the year, it is expected to go up little by little and its maximum price could reach about ₹3500. So, the stock may trade between ₹2950 and ₹3500 during the year.

Cipla Share Price Target 2029

In 2029, the minimum price of Cipla shares will be ₹3600. Over the year, it is expected to go up little by little and its maximum price could reach about ₹3950. So, the stock may trade between ₹3600 and ₹3950 during the year.

Cipla Share Price Target 2030

In 2030, the minimum price of Cipla shares will be ₹4100. Over the year, it is expected to go up little by little and its maximum price could reach about ₹4600. So, the stock may trade between ₹4100 and ₹4600 during the year.

Also Read: MRF Share Price Target 2025, 2026, 2027 to 2030

Cipla Company Financials

In the financials section of Cipla Ltd, we will discuss its income statement and balance sheet, so you can decide whether this stock is good for you or not for trade.

Cipla Income Statement

The company earned ₹67.20 billion this quarter, which is about 9% more than it made last year. To run the business, it spent ₹29.47 billion a small increase. After all costs were paid, the company made a healthy profit of ₹12.22 billion, which is a big 30% jump. That means it kept ₹18 out of every ₹100 it earned, showing its profit margin was strong at 18.18%. Each share earned ₹15.12, and that’s also grown by the same 30%. The company’s earnings before tax and other charges (EBITDA) were ₹15.60 billion. It paid around 19% of its profit in taxes.

Cipla Balance Sheet

The company’s total assets all the valuable things it owns are worth ₹373.87 billion now, which is over 14% more than last year. Out of that, ₹106.17 billion is just cash or short-term savings, which grew a lot this year. The company owes ₹60.98 billion in total, which is only a small increase. After paying off its debts, it still owns ₹312.89 billion that’s called equity. Each share is valued at about 3.85 times more than the company’s base worth. It’s also using its money smartly, with an 11.02% return on the capital it invests.

Cipla Peer Companies

The peer companies of Cipla which are in tough competition are Sun Pharmaceutical Industries Ltd, Divi’s Laboratories Ltd, Torrent Pharmaceuticals Ltd, Dr. Reddy’s Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Abbott India Ltd, are Alkem Laboratories Ltd.

F&Q

Rishi Gupta